FTC To Probe Pharma Middlemen Over High Drug Prices
The Federal Trade Commission said Tuesday it has launched a probe into the business practices of vertically integrated pharmacy benefit managers, requiring the six largest companies in the industry to hand...To view the full article, register now.
Already a subscriber? Click here to view full article